[1]Cavrini;Gatti;Roveri;Cesaroni;Mazzoni;Fiorentini[ArchivderPharmazie,1984,vol.317,#8,p.662-668]
[2]Na,Young-Min;LeBorgne,Marc;Pagniez,Fabrice;LeBaut,Guillaume;LePape,Patrice[EuropeanJournalofMedicinalChemistry,2003,vol.38,#1,p.75-87]
[3]Marchand;LeBorgne;Duflos;Robert-Piessard;LeBaut;Ahmadi;Hartmann;Palzer[PharmacyandPharmacologyCommunications,1998,vol.4,#4,p.211-218]
[4]Wang,Guangcheng;Li,Chunyan;He,Lin;Lei,Kai;Wang,Fang;Pu,Yuzi;Yang,Zhuang;Cao,Dong;Ma,Liang;Chen,Jinying;Sang,Yun;Liang,Xiaolin;Xiang,Mingli;Peng,Aihua;Wei,Yuquan;Chen,Lijuan[BioorganicandMedicinalChemistry,2014,vol.22,#7,p.2060-2079]
[5]Guengoer,Timur;Malabre,Patrice;Teulon,Jean-Marie;Camborde,Francoise;Meignen,Joelle;etal.[JournalofMedicinalChemistry,1994,vol.37,#25,p.4307-4316]
[6]Chadha,Navriti;Silakari,Om[BioorganicandMedicinalChemistryLetters,2017,vol.27,#11,p.2324-2330]
[7]James,DavidA.;Koya,Keizo;Li,Hao;Chen,Shoujun;Xia,Zhiqiang;Ying,Weiwen;Wu,Yaming;Sun,Lijun[BioorganicandMedicinalChemistryLetters,2006,vol.16,#19,p.5164-5168]
[8]Zhu,Wufu;Liu,Yajing;Zhai,Xin;Wang,Xiao;Zhu,Yan;Wu,Di;Zhou,Hongyu;Gong,Ping;Zhao,Yanfang[EuropeanJournalofMedicinalChemistry,2012,vol.57,p.162-175]
[9]Singh,PankajKumar;Silakari,Om[BioorganicChemistry,2018,vol.79,p.163-170]
[10]Liu,Hong-Min;Suo,Feng-Zhi;Li,Xiao-Bo;You,Ying-Hua;Lv,Chun-Tao;Zheng,Chen-Xing;Zhang,Guo-Chen;Liu,Yue-Jiao;Kang,Wen-Ting;Zheng,Yi-Chao;Xu,Hai-Wei[EuropeanJournalofMedicinalChemistry,2019,vol.175,p.357-372]
[11]Bai,Yujia;Yuan,Jinping;Hu,Xiaoyue;Antilla,JonC.[OrganicLetters,2019,vol.21,#12,p.4549-4553]
[12]Zhu,Wufu;Liu,Yajing;Zhao,Yanfang;Wang,Haiyan;Tan,Li;Fan,Weijie;Gong,Ping[ArchivderPharmazie,2012,vol.345,#10,p.812-821,10]
[1]Moriya,Tamon;Hagio,Katsuaki;Yoneda,Naoto[Chemicalandpharmaceuticalbulletin,1980,vol.28,#6,p.1711-1721]
[1]Andreani;Rambaldi;Bonazzi;Andreani;Bossa;Galatulas[ArchivderPharmazie,1984,vol.317,#10,p.847-851]
[2]Locationinpatent:experimentalpartWu,Shuhong;Wang,Li;Guo,Wei;Liu,Xiaoying;Liu,Jinsong;Wei,Xiaoli;Fang,Bingliang[JournalofMedicinalChemistry,2011,vol.54,#8,p.2668-2679]
[1]Cavrini;Gatti;Roveri;Cesaroni;Mazzoni;Fiorentini[ArchivderPharmazie,1984,vol.317,#8,p.662-668]
[2]Marchand;LeBorgne;Duflos;Robert-Piessard;LeBaut;Ahmadi;Hartmann;Palzer[PharmacyandPharmacologyCommunications,1998,vol.4,#4,p.211-218]
[3]Na,Young-Min;LeBorgne,Marc;Pagniez,Fabrice;LeBaut,Guillaume;LePape,Patrice[EuropeanJournalofMedicinalChemistry,2003,vol.38,#1,p.75-87]
[4]Locationinpatent:experimentalpartWu,Shuhong;Wang,Li;Guo,Wei;Liu,Xiaoying;Liu,Jinsong;Wei,Xiaoli;Fang,Bingliang[JournalofMedicinalChemistry,2011,vol.54,#8,p.2668-2679]
[1]Guengoer,Timur;Malabre,Patrice;Teulon,Jean-Marie;Camborde,Francoise;Meignen,Joelle;etal.[JournalofMedicinalChemistry,1994,vol.37,#25,p.4307-4316]
Title: Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.
Journal: Journal of medicinal chemistry 20110428
Title: (2Z,3E)-2-{[1-(4-Chloro-benz-yl)-1H-indol-3-yl]methyl-idene}quinuclidin-3-one oxime.
Journal: Acta crystallographica. Section E, Structure reports online 20110301
Title: Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.
Journal: PloS one 20110101
Title: Oxidative stress in NSC-741909-induced apoptosis of cancer cells.
Journal: Journal of translational medicine 20100101
Title: Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).
Journal: Molecular cancer therapeutics 20090201
Title: Guo W, et al. Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota. Cancer Res. 2008 Sep 15;68(18):7403-8.
Title: Guo W, et al. Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl-1H-indole-3-carboxaldehyde (oncrasin-1). Mol Cancer Ther. 2009 Feb;8(2):441-8.
